CMIG4:BMFBOVESPACompanhia Energetica de Minas Gerais SA Pfd Analysis
Data as of 2026-07-30 - not real-time
R$11.23
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
CMIG4 is trading at R$11.23, just above its 20‑day SMA (R$11.09) and 50‑day SMA (R$10.97), while the 200‑day SMA sits higher at R$11.50, indicating a neutral price stance. The MACD histogram is positive and the signal line is bullish, and the RSI sits at 54, suggesting modest upward momentum without being overbought. The stock is testing the resistance zone around R$11.42 after bouncing off support near R$10.77, with volume trending lower, which could limit a breakout. Fundamentally, the company trades at a trailing P/E of 6.6 versus an industry average of 20.6, and its price‑to‑book is just above 1, signaling a cheap valuation on traditional metrics. However, the DCF‑derived fair value of roughly R$9.34 places the market price about 12% above intrinsic estimates, flagging potential overvaluation. Dividend yield remains exceptionally high at 11.6% with a payout ratio near 99%, but free cash flow is negative and debt‑to‑equity stands above 69%, raising concerns about dividend sustainability. The utility sector’s regulated nature provides stability, yet Brazil’s macro‑environment and currency dynamics add layers of risk. Overall, the blend of attractive yield, cheap multiples, and overvalued price creates a mixed outlook that hinges on the company’s ability to generate cash and manage leverage.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price near resistance with decreasing volume
- Technical indicators showing limited upside
- Market price above DCF fair value
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- High dividend yield but questionable sustainability
- Low P/E relative to peers offering value appeal
- Elevated leverage and negative free cash flow
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- Regulated utility business provides stable cash flows over time
- Potential price correction aligning market price with intrinsic value
- Attractive dividend yield for income‑focused investors
Key Metrics & Analysis
Financial Health
Revenue Growth6.30%
Profit Margin11.15%
P/E Ratio6.6
ROE17.04%
ROA5.93%
Debt/Equity69.26
P/B Ratio1.1
Op. Cash FlowR$3.8B
Free Cash FlowR$-3623300352
Industry P/E20.6
Technical Analysis
TrendNeutral
RSI54.5
SupportR$10.77
ResistanceR$11.42
MA 20R$11.09
MA 50R$10.97
MA 200R$11.50
MACDBullish
VolumeDecreasing
Fear & Greed Index90.91
Valuation
Fair ValueR$9.34
Target PriceR$12.54
Upside/Downside11.63%
GradeOvervalued
TypeValue
Dividend Yield11.64%
Risk Assessment
Beta0.41
Volatility23.23%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.